产品中心 抗体 功能性抗体

所有图片(1/1)

Invivo anti-Human CD19 Recombinant mAb

B-lymphocyte antigen CD19,B-lymphocyte surface antigen B4,Differentiation antigen CD19,T-cell surface antigen Leu-12

价格 1,050.00 供应商现货 : 3-5个工作日
货号 S0B7116
规格
数量
收藏 分享

产品介绍 评论(0)

产品规格
  • 宿主来源

    Mouse
  • 抗原名称

    CD19
  • 分子别名

    B-lymphocyte antigen CD19; B-lymphocyte surface antigen B4; Differentiation antigen CD19; T-cell surface antigen Leu-12
  • 细胞定位

    Cell membrane
  • Accession

    P15391
  • 克隆号

    4G7
  • 抗体类型

    Mouse mAb
  • 同型对照

    S0B0760
  • 反应种属 ?

    Hu
  • 阳性样本

    Human PBMC
  • 纯化方式

    Protein G
  • 浓度

    5 mg/ml
  • 纯度

    >95% (Determined by SDS-PAGE)
  • 内毒素含量

    <1EU/mg
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS pH7.4, containing no preservative

  • 储存条件

    2 to 8 °C for 2 weeks under sterile conditions;
    -20 °C for 3 months under sterile conditions;
    -80 °C for 24 months under sterile conditions.
    Please avoid repeated freeze-thaw cycles.

  • 应用

    Functional assays

    FCM

  • 稀释度

    应用 稀释度 推荐种属
    FCM 1:1000 Hu
背景介绍
  • CD19, also known as B-lymphocyte antigen CD19 or B-Lymphocyte Surface Antigen B4, is a 95 kDa type I transmembrane glycoprotein that belongs to the immunoglobulin superfamily and is encoded by the CD19 gene. It is primarily expressed on all B lineage cells, from early pro-B cells to plasma cells, and plays a crucial role in B cell development, activation, and signaling. As a co-receptor, CD19 enhances signaling through the B cell receptor (BCR) complex, lowering the threshold for B cell activation and promoting B cell proliferation and differentiation. It forms a complex with CD21, CD81, and other proteins, which helps in the recognition of antigens tagged with complement and amplifies BCR signaling. CD19 is also a biomarker for B cell-related diseases and a target for immunotherapies, including monoclonal antibodies and CAR-T cell therapies, due to its consistent expression on B cells and B cell malignancies.

  • 流式分析

    • Flow cytometric analysis of Human PBMCs (human peripheral blood mononuclear cells) labeled with anti – Human CD19 antibody at 1/1000 dilution (0.5 μg) / (right panel) compared with a Mouse IgG1 Isotype Control / (left panel). Goat Anti- Mouse IgG Alexa Fluor® 488 was used as the secondary antibody. Then cells were stained with CD3 - Brilliant Violet 421™ antibody separately. Flow cytometry and data analysis were performed using Agilent NovoCyte Quanteon and FlowJo™ software.

评论(0)